These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 27336913

  • 1. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Srisomboon J, Intaraphet S, Siriaunkgul S.
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [Abstract] [Full Text] [Related]

  • 2. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Intaraphet S, Siriaunkgul S.
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [Abstract] [Full Text] [Related]

  • 3. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J, Zhang D, Yang Z, Wang X, Wang D.
    BMC Cancer; 2020 May 19; 20(1):443. PubMed ID: 32429919
    [Abstract] [Full Text] [Related]

  • 4. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo S, Nagai K, Oki A, Ochi H, Morishita Y, Noguchi M, Yoshikawa H.
    Int J Clin Oncol; 2015 Oct 19; 20(5):974-81. PubMed ID: 25652908
    [Abstract] [Full Text] [Related]

  • 5. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China.
    Song F, Yan P, Huang X, Wang C, Qu X, Du H, Wu R.
    BMC Infect Dis; 2021 Apr 30; 21(1):400. PubMed ID: 33931022
    [Abstract] [Full Text] [Related]

  • 6. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 Apr 30; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 7. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F, Du H, Wang C, Huang X, Wu R, CHIMUST team.
    PLoS One; 2020 Apr 30; 15(6):e0234518. PubMed ID: 32525936
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Song F, Belinson JL, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    Gynecol Oncol; 2021 Aug 30; 162(2):322-330. PubMed ID: 34059349
    [Abstract] [Full Text] [Related]

  • 9. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
    Jiang MY, Feng RM, Wang L, Li TY, Zhang AA, Cui JF, Pan QJ, Zhang X, Liu ML, Gao F, Chen W, Qiao YL.
    Zhonghua Zhong Liu Za Zhi; 2018 Oct 23; 40(10):750-756. PubMed ID: 30392339
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K, Moysiadis T, Angelis E, Kaufmann A, Skenderi A, Jansen-Duerr P, Lekka I, Kilintzis V, Angelidou S, Katsiki E, Hagemann I, Tsertanidou A, Koch I, Boecher O, Soutschek E, Maglaveras N, Agorastos T.
    Arch Gynecol Obstet; 2017 May 23; 295(5):1247-1257. PubMed ID: 28337594
    [Abstract] [Full Text] [Related]

  • 11. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R.
    Gynecol Oncol; 2017 Jan 23; 144(1):51-56. PubMed ID: 28094038
    [Abstract] [Full Text] [Related]

  • 12. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J, FRIDA Study Group..
    JAMA Netw Open; 2019 Nov 01; 2(11):e1915781. PubMed ID: 31747033
    [Abstract] [Full Text] [Related]

  • 13. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL.
    Cancer Prev Res (Phila); 2020 Feb 01; 13(2):163-172. PubMed ID: 31871224
    [Abstract] [Full Text] [Related]

  • 14. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.
    Dijkstra MG, van Niekerk D, Rijkaart DC, van Kemenade FJ, Heideman DA, Snijders PJ, Meijer CJ, Berkhof J.
    Cancer Epidemiol Biomarkers Prev; 2014 Jan 01; 23(1):55-63. PubMed ID: 23733907
    [Abstract] [Full Text] [Related]

  • 15. Clinical Evaluation of DNA Ploidy for the Triage of HPV-Positive Chinese Women During Cervical Cancer Screening.
    Cang W, Li Q, Gu L, Hong Z, Hu Y, Di W, Qiu L.
    Cancer Prev Res (Phila); 2021 Mar 01; 14(3):355-362. PubMed ID: 33229338
    [Abstract] [Full Text] [Related]

  • 16. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [Abstract] [Full Text] [Related]

  • 17. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z, Li Y, Chen A, Song M, Zhang Y.
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec 20; 207():32-36. PubMed ID: 27816739
    [Abstract] [Full Text] [Related]

  • 18. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.
    Int J STD AIDS; 2008 Jun 20; 19(6):385-92. PubMed ID: 18595876
    [Abstract] [Full Text] [Related]

  • 19. Population-based cervical cancer screening using high-risk HPV DNA test and liquid-based cytology in northern Thailand.
    Siriaunkgul S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Kasatpibal N, Khunamornpong S.
    Asian Pac J Cancer Prev; 2014 Jun 20; 15(16):6837-42. PubMed ID: 25169534
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M, Alonso I, Rodriguez-Trujillo A, Bernal S, Geraets D, Guimerà N, Torne A, Ordi J.
    J Virol Methods; 2017 Oct 20; 248():238-243. PubMed ID: 28739302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.